Wearable Therapeutic Device for Migraine Treatment
Theranica has developed Nerivio™, an FDA authorized easy-to-use, non-invasive, safe and non-chemical wearable device for the acute treatment of migraines.
The wearable, Nerivio™, is applied to the upper arm and activated by a smartphone app which begins a 45-minute session that stimulates endogenous pain inhibitory mechanisms in the brain through electrical neuromodulation.
Results from numerous large-scale clinical studies show efficacy results as good as the gold standard pharmacological treatments with a benign safety profile. Data collection is core to the platform Data is central to the platform, helping patients diarize their migraines, share information with MDs, and personalize their settings.